Olanzapine 5 mg plus standard antiemetic therapy for the prevention of chemotherapy-induced nausea and vomiting (J-FORCE): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
Hashimoto, Hironobu, Abe, Masakazu, Tokuyama, Osamu, Mizutani, Hideaki, Uchitomi, Yosuke, Yamaguchi, Takuhiro, Hoshina, Yukari, Sakata, Yasuhiko, Takahashi, Takako Yanai, Nakashima, Kazuhisa, Nakao, MJournal:
The Lancet Oncology
DOI:
10.1016/S1470-2045(19)30678-3
Date:
December, 2019
File:
PDF, 716 KB
2019
File converter
More search results
More benefits 
